Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly - PubMed (original) (raw)
Review
Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly
Ivan K Chinn et al. J Allergy Clin Immunol. 2011 Jun.
Abstract
DiGeorge anomaly can affect both thymic and parathyroid function. Although athymia is corrected by allogeneic thymus transplantation, treatment options for hypoparathyroidism have been unsatisfactory. Parathyroid transplantation offers the potential for definitive cure but remains challenging because of graft rejection. Some allogeneic parathyroid grafts have functioned in adult recipients in the context of immunosuppression for renal transplantation. Other efforts have attempted to reduce the allogenicity of the parathyroid grafts through manipulation of the parathyroid tissues before transplantation (by using encapsulation or special culture techniques). Recently, we demonstrated the efficacy of parental parathyroid transplantation when combined with allogeneic thymus transplantation in an infant with complete DiGeorge anomaly. The recipient developed tolerance toward the parathyroid donor. The parathyroid graft has functioned for 5 years after transplantation without the need for continued immunosuppression or calcium supplementation. We observed that matching of the allogeneic thymus graft to the parathyroid donor HLA class II alleles that are unshared with the recipient appears to be associated with the induction of tolerance toward the parathyroid graft. Further work is needed to determine the optimal means for using combined allogeneic thymus and parental parathyroid transplantation to correct hypoparathyroidism in patients with both complete and partial DiGeorge anomaly.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
References
- DiGeorge AM. Discussion of Cooper MD, Peterson RDA, Good RA. A new concept of cellular basis of immunity. J Pediatr. 1965;67:907.
- Müller W, Peter H, Wilken M, Juppner H, Kallfelz HC, Krohn HP, et al. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr. 1988;147:496–502. - PubMed
- Sullivan KE. Chromosome 22q11.2 Deletion Syndrome: DiGeorge Syndrome/Velocardiofacial Syndrome. Immunol Allergy Clin. 2008;28:353–366. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AI047040/AI/NIAID NIH HHS/United States
- K12 HD043494-10/HD/NICHD NIH HHS/United States
- T32 AI007062/AI/NIAID NIH HHS/United States
- M03 RR 30/RR/NCRR NIH HHS/United States
- L40 AI079879-01/AI/NIAID NIH HHS/United States
- R21 AI 060967/AI/NIAID NIH HHS/United States
- T32 AI 007062-28A2/AI/NIAID NIH HHS/United States
- L40 AI079879/AI/NIAID NIH HHS/United States
- R21 AI060967-02/AI/NIAID NIH HHS/United States
- R01 AI 047040/AI/NIAID NIH HHS/United States
- R01 AI047040-12/AI/NIAID NIH HHS/United States
- K12 HD043494/HD/NICHD NIH HHS/United States
- 2 K12 HD043494/HD/NICHD NIH HHS/United States
- R21 AI060967/AI/NIAID NIH HHS/United States
- T32 AI007062-28A2/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials